Learning disability and oligodendrocyte myelin glycoprotein (OMGP) gene in neurofibromatosis type 1

Turkish Journal of Pediatrics

Volumn 53, Issue 1, 2011, Pages 75-78

  Terzi, Yunus Kasim ^a   Oǧuzkan Balci, Sibel ^b   Anlar, Banu ^a   Erdoǧan Bakar, Emel ^a   Ayter, Şükriye ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Cognitive; Learning disability; Neurofibromatosis type 1; Oligodendrocyte myelin glycoprotein; OMGP

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MEMBRANE ANTIGEN; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; HUMAN; LEARNING DISORDER; NEUROFIBROMATOSIS; PHENOTYPE; PROTEIN PROCESSING; GENETICS; NUCLEOTIDE SEQUENCE;

ANTIGENS, SURFACE; DNA MUTATIONAL ANALYSIS; HUMANS; LEARNING DISORDERS; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROFIBROMATOSIS 1; PHENOTYPE;

EID: 79958755044     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. North KN. Neurofibromatosis type 1. Am J Med Genet 2000; 97: 119-127.
2. National Institutes of Health. Consensus Development Conference Statement: Neurofibromatosis. Arch Neurol 1988; 45: 575-578.
3. Levine TM, Materek A, Abel J, O'Donnell M, Cutting LE. Cognitive profile of neurofibromatosis type 1. Semin Pediatr Neurol 2006; 13: 8-20.
4. Moore BD. Potential influences on mathematical difficulties in children and adolescents with neurofibromatosis, type 1. Dev Disabil Res Rev 2009; 15: 45-51.
5. Kavale KA, Forness SR. What definitions of learning disability say and don't say: a critical analysis. J Learn Disabil 2000; 33: 239-256.
6. Ferner RE, Hughes RA, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 1996; 138: 125-133.
7. Upadhyaya M, Osborn MJ, Maynard J, Kim MR, Tamanoi F, Cooper DN. Mutational and functional analyses of the neurofibromatosis type 1 (NF1) gene. Hum Genet 1997; 99: 88-92.
8. Habib AA, Gulcher JR, Hognason T, Zheng L, Stefánsson K. The OMgp gene, a second growth suppressor within the NF1 gene. Oncogene 1998; 16: 1525-1531.
9. Upadhyaya M, Ruggieri M, Maynard J, et al. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 1998; 102: 591-597.
10. Vourc'h P, Martin I, Marouillat S, et al. Molecular analysis of the oligodendrocyte myelin glycoprotein gene in autistic disorder. Neurosci Lett 2003; 338: 115-118.
11. Erdoǧan-Bakar E, Cinbiş M, Ozyürek H, Kiriş N, Altunbaşak S, Anlar B. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings. Turk J Pediatr 2009; 51: 565-571.
12. Venturin M, Moncini S, Villa V, et al. Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation. Neurogenetics 2006; 7: 59-66.
13. Das UN. Can memory be improved? A discussion on the role of ras, GABA, acetylcholine, NO, insulin, TNF-alpha, and long-chain polyunsaturated fatty acids in memory formation and consolidation. Brain Dev 2003; 25: 251-261.